MarketPulse

BioNTech

2 articles
BenzingaBenzinga··Erica Kollmann

BioNTech Stock Crashes 17.67% on Weak Guidance and Founder Exit Plans

BioNTech shares plummeted as the biotech firm issued lower 2026 revenue guidance and co-founders announced plans to exit by year-end 2026.
BNTXstock declinerevenue guidance
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

BioNTech Faces Shareholder Investigation Amid Losses and Founder Exodus

Law firm investigates $BNTX following €305M Q4 loss, plunging COVID vaccine demand, and planned founder departure, examining potential securities law violations.
BNTXfederal securities lawssecurities fraud investigation